Alnylam Pharmaceuticals Inc (NAS:ALNY)
$ 265.9 -3.05 (-1.13%) Market Cap: 34.30 Bil Enterprise Value: 33.17 Bil PE Ratio: 0 PB Ratio: 1,063.60 GF Score: 78/100

Alnylam Pharmaceuticals Inc at H C Wainwright Global Life Sciences Conference (Virtual) Transcript

Mar 09, 2021 / 12:00PM GMT
Release Date Price: $137.68 (-0.68%)
Patrick Ralph Trucchio
H.C. Wainwright & Co, LLC, Research Division - MD of Equity Research & Senior Healthcare Analyst

Hello, everyone, and thank you for joining the H.C. Wainwright 2021 Global Life Sciences Conference.

My name is Patrick Trucchio, and I'm a biotech analyst at H.C. Wainwright. While we're virtual this year, we're confident we're going to be able to provide value to you with more than 425 companies presenting at this conference as well as in interactions through one-on-one meetings.

H.W. Wainwright is a full-service investment bank dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. We have a total of 18 publishing senior analysts and 493 companies covered across all sectors. Please visit hcwco.com for more details.

From a logistics standpoint, please make sure to reference your virtual conference online portal that provides you individual links to your meetings and all presentations. Panels and all presentations are live and on-demand online from March

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot